These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7849711)

  • 1. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
    Ueki K; Rubio MP; Ramesh V; Correa KM; Rutter JL; von Deimling A; Buckler AJ; Gusella JF; Louis DN
    Hum Mol Genet; 1994 Oct; 3(10):1841-5. PubMed ID: 7849711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor.
    Raffel C; Ueki K; Harsh GR; Louis DN
    Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
    Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
    Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias.
    Guidal-Giroux C; Gérard B; Cavé H; Duval M; Rohrlich P; Elion J; Vilmer E; Grandchamp B
    Br J Haematol; 1996 Feb; 92(2):410-9. PubMed ID: 8603008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas.
    Walker DG; Duan W; Popovic EA; Kaye AH; Tomlinson FH; Lavin M
    Cancer Res; 1995 Jan; 55(1):20-3. PubMed ID: 7805033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
    Schmidt EE; Ichimura K; Reifenberger G; Collins VP
    Cancer Res; 1994 Dec; 54(24):6321-4. PubMed ID: 7987821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ; Aldaz CM
    Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H; Smith AP; Gaz RD; Arnold A
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
    Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Liu Q; Neuhausen S; McClure M; Frye C; Weaver-Feldhaus J; Gruis NA; Eddington K; Allalunis-Turner MJ; Skolnick MH; Fujimura FK
    Oncogene; 1995 Mar; 10(6):1061-7. PubMed ID: 7700630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
    Li YJ; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
    Oncogene; 1995 Aug; 11(3):597-600. PubMed ID: 7630644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the P16INK4/MTS1 gene by a chromosome translocation t(9;14)(p21-22;q11) in an acute lymphoblastic leukemia of B-cell type.
    Duro D; Bernard O; Della Valle V; Leblanc T; Berger R; Larsen CJ
    Cancer Res; 1996 Feb; 56(4):848-54. PubMed ID: 8631023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers.
    Muzeau F; Fléjou JF; Thomas G; Hamelin R
    Int J Cancer; 1997 Jul; 72(1):27-30. PubMed ID: 9212218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.